MedTrace Logo

Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis

NCT06965322 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-12-02

No results posted yet for this study

Summary

The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).

Conditions

  • Rheumatic Arthritis
  • Interstitial Lung Disease in Patients With Rheumatoid Arthritis

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-11
Primary Completion
2028-05-30
Completion
2029-09-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06965322 on ClinicalTrials.gov